Atlas Trials

Hybrid SPECT/CTCA for the Assessment of the Presence and Hemodynamic Significance of CAD in Asymptomatic Patients.

Clinical trial NCT01239446 · UNKNOWN

Trial details

NCT number
NCT01239446
Sponsor
Rambam Health Care Campus
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Hodgkin Lymphoma Treated With Mediastinal Irradiation
Start date
2011-01-01
Primary completion
2012-01-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.